Replies to post #363399 on Anavex Life Sciences Corp (AVXL)

[Investor2014]

Pure confirmation bias!!!

Most of them out of a handful over 6 years old and anecdotal, none of them with Parkinson's Disease Dementia, none with Rett walking that I've seen.

There are plenty of living, breathing, walking around, talking examples making videos of Blarcamesine overcoming incurable diseases. Rett, Alzheimer’s, Parkinson’s Disease Dementia.

[BIOChecker4]

I don’t “degrade” Anavex. I think the science has potential, and the question of efficacy of A2-73 and approvability should be played out. My issue with Anavex is senior management (Missling) and the board of directors (the people who have a fiduciary responsibility to prioritize shareholder value). We have a self-serving CEO with no credibility on Wall Street or pharma and a board of directors who are merely buddies of Missling.

I think shareholders would be better served by recruiting a reputable senior leadership team with a strong track record of success in drug development, regulatory approvals and commercialization, and a BOD that would put shareholder value first.

Being critical of the leadership of Anavex is not degrading Anavex the company, unless you consider Missling to be Anavex, which I do not.